Soluble Fas in the serum of patients with non-Hodgkin's lymphoma: Higher concentrations in angioimmunoblastic T-cell lymphoma

American Journal of Hematology

Volumn 58, Issue 4, 1998, Pages 334-336

  Yufu, Yuji ^a   Choi, Ilseung ^a   Hirase, Nobuhisa ^b   Tokoro, Akihiro ^a   Noguchi, Yumi ^a   Goto, Tatsuro ^a   Uike, Naokuni ^a   Kozuru, Mitsuo ^a  

^a NATIONAL KYUSHU CANCER CENTER   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Angioimmunoblastic T cell lymphoma; Apoptosis; Non Hodgkin's lymphoma; Soluble Fas

Indexed keywords

FAS ANTIGEN;

ADULT; ANGIOIMMUNOBLASTIC LYMPHADENOPATHY; ARTICLE; AUTOIMMUNE DISEASE; B CELL LYMPHOMA; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; NATURAL KILLER CELL; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; SERUM; T CELL LYMPHOMA;

EID: 0031815270     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199808)58:4<334::AID-AJH15>3.0.CO;2-7     Document Type: Article

References (10)

1. Nagata S, Golstein P: The Fas death factor. Science 267:1449-1456, 1995.
2. Drappa J, Vaishnaw AK, Sullivan KE, Chu J-L, Elkon KB: Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity. N Engl J Med 335: 1643-1649, 1996.
3. Fisher GH, Rosenberg FJ, Straus SE, Dale JK, Middleton LA, Lin AY, Strober W, Lenardo MJ, Puck JM: Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81:935-946, 1995.
4. Rieux-Laucat F, Le Deist F, Hivroz C, Roberts IAG, Debatin KM, Fischer A, de Villartay, JP: Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268:1347-1349, 1995.
5. Cheng J, Zhou T, Liu C, Shapiro JP, Brauer MJ, Kiefer MC, Barr PJ, Mountz JD: Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 263:1759-1762, 1994.
6. Papoff G, Cascino I, Eramo A, Starace G, Lynch DH, Ruberti G: An N-terminal domain shared by Fas/Apo-1 (CD95) soluble variants prevents cell death in vitro. J Immunol 156:4622-4630, 1996.
7. Feller AC, Griesser H, Schilling CV, Wacker HH, Dallenbach F, Bartels H, Kuse R, Mak TW, Lennert K: Clonal gene rearrangement patterns correlate with immunophenotype and clinical parameters in patients with angioimmunoblastic lymphadenopathy. Am J Pathol 133: 549-556, 1988.
8. Knecht H: Angioimmunoblastic lymphadenopathy: Ten years' experience and state of current knowledge. Semin Hematol 26:208-215, 1989.
9. Seishima M, Takemura M, Saito K, Sano H, Minatoguchi S, Fujiwara H, Hachiya T, Noma A: Highly sensitive ELISA for soluble Fas in serum: Increased soluble Fas in the elderly. Clin Chem 42:1911-1914, 1996.
10. Knipping E, Debatin K-M, Stricker K, Heilig B, Eder A, Krammer PH: Identification of soluble APO-1 in supernatants of human B-and T-cell lines and increased serum levels in B-and T-cell leukemias. Blood 85:1562-1569, 1995.